Skip to content

Clinical trials

Phase 2 Post-Acute COVID-19 Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Post-Acute COVID-19 Syndrome Phase: Phase 2 Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20202
20217
20229
202327
202412
202512
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Recruiting11
Active, not recruiting7
Unknown status6
Not yet recruiting4
Terminated3
Withdrawn3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kanecia Obie Zimmerman5
Charite University, Berlin, Germany3
Duke University3
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia2
Icahn School of Medicine at Mount Sinai2
ImmunityBio, Inc.2
AIM ImmunoTech Inc.1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
AgelessRx1
Axcella Health, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Post-Acute COVID-19 Syndrome76
COVID-1921
Fatigue9
Fatigue Syndrome, Chronic5
Mental Fatigue5
Cognitive Dysfunction4
Cognition Disorders3
Infections3
Parasomnias3
Postural Orthostatic Tachycardia Syndrome3

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.